Capricor Therapeutics, Inc.
CAPR
$6.97
$0.081.16%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -40.47M | -34.11M | -27.95M | -24.31M | -22.29M |
| Total Depreciation and Amortization | 1.43M | 1.36M | 1.27M | 1.17M | 1.07M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.83M | 9.29M | 8.97M | 8.44M | 7.37M |
| Change in Net Operating Assets | -10.78M | -13.33M | -16.24M | -16.37M | -11.75M |
| Cash from Operations | -40.00M | -36.79M | -33.95M | -31.08M | -25.60M |
| Capital Expenditure | -1.54M | -1.53M | -2.11M | -2.26M | -2.05M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -114.64M | 2.87M | 9.16M | 1.08M | 7.16M |
| Cash from Investing | -116.18M | 1.34M | 7.05M | -1.18M | 5.11M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 152.77M | 94.85M | 27.75M | 27.87M | 25.58M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 152.77M | 94.85M | 27.75M | 27.87M | 25.58M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.41M | 59.39M | 851.20K | -4.39M | 5.09M |